Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study investigated the association of Mediterranean diet (MED) adherence with chronic constipation and chronic diarrhea, using a nationally representative sample of U.S. adults. This cross-sectional study analyzed 11,612 participants from the 2005 to 2010 National Health and Nutrition Examination Survey (NHANES). Adherence to MED was assessed through the alternative Mediterranean diet (aMED) index. Bowel habits were categorized using the Bristol Stool Form Scale (BSFS), with chronic constipation defined as BSFS types 1-2, and chronic diarrhea as types 6-7, based on the usual or most common stool type reported by participants. Multivariate logistic regression models and subgroup analyses were employed to assess associations of MED adherence with chronic constipation and chronic diarrhea. Restricted cubic spline analyses were conducted to explore potential nonlinear relationships. Higher aMED scores were associated with a lower likelihood of chronic constipation (OR: 0.82, 95% CI: 0.75, 0.89). Participants in the highest aMED category had 43% lower odds of chronic constipation compared to those in the lowest category (OR: 0.57, 95% CI: 0.43, 0.75). Subgroup analysis indicated that this association was strongest among obese individuals (BMI ≥ 30 kg/m) (OR: 0.69, 95% CI: 0.58, 0.82). No significant associations were observed between aMED scores and chronic diarrhea in the fully adjusted model. Adherence to the Mediterranean diet was significantly associated with lower prevalence of chronic constipation but showed no significant relationship with chronic diarrhea in the U.S. population. Further longitudinal research is needed to clarify causality and explore population-specific effects.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351127PMC
http://dx.doi.org/10.1002/fsn3.70809DOI Listing

Publication Analysis

Top Keywords

chronic constipation
28
chronic diarrhea
24
mediterranean diet
16
chronic
13
adherence chronic
12
constipation chronic
12
association mediterranean
8
med adherence
8
amed scores
8
associated lower
8

Similar Publications

Introduction: Pharmacological therapies for chronic idiopathic constipation (CIC) are useful, but many patients report dissatisfaction from a lack of efficacy and occurrence of adverse events. The vibrating capsule (VC) is an FDA approved non-pharmacologic, treatment for CIC. However, its long-term usefulness in a community setting is unknown.

View Article and Find Full Text PDF

Pain is prevalent and a major source of disability after a traumatic brain injury (TBI) and a spinal cord injury (SCI). With a view of reducing the pain burden in neurotrauma, this study aimed to describe the use of pain management strategies and the adverse effects of opioids in patients with TBI and SCI. We collected data at hospital discharge (T1) and at 3 months post-injury (T2).

View Article and Find Full Text PDF

Chronic intestinal pseudo-obstruction (CIPO) is a rare and severe intestinal motility disorder with poor long-term prognosis and high mortality rate, especially when the small intestine is involved. Due to the non-specificity of clinical symptoms, CIPO has long faced diagnostic challenges. With the advancements of sequencing technology, many hereditary CIPOs have been identified.

View Article and Find Full Text PDF

Lactococcus formosensis and its metabolite 4-acetamidobutanoic acid induced caspase-11 dependent myenteric neuronal pyroptosis in intractable functional constipation.

Microbiol Res

September 2025

Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China. Electronic address:

Intractable functional constipation (IFC), a severe form of chronic constipation characterized by slow transit and resistance to conventional treatments, posed a significant clinical challenge. Here, we identified Lactococcus formosensis (Lf), a Gram-positive bacterium prevalent in IFC patients, as a novel contributor to intestinal motility impairment. Clinically, IFC patients exhibited increased colonic mucosal colonization of Lf and significant myenteric neuronal loss and pyroptosis, particularly in excitatory choline acetyltransferase (ChAT) neurons, but not inhibitory neuronal nitric oxide synthase (nNOS) neurons.

View Article and Find Full Text PDF

A potential association between tirzepatide and hypercalcemia in the setting of chronic hydrochlorothiazide use.

Endocrinol Diabetes Metab Case Rep

July 2025

Department of Internal Medicine, Medical City Arlington, Arlington, Texas, USA.

Summary: Hypercalcemia is a prevalent electrolyte disturbance commonly associated with primary hyperparathyroidism, cancer, or medication adverse effects. Thiazide diuretics reduce urinary calcium excretion, increasing calcium reabsorption and hypercalcemia. Tirzepatide, a dual GIP and GLP-1 receptor agonist, is increasingly used for type 2 diabetes and obesity.

View Article and Find Full Text PDF